Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher H George

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|December 5, 2022
How good are our models of cardiovascular disease? Introducing our themed issue on preclinical models for cardiovascular disease researchChristopher G Sobey, Grant R Drummond, Christopher H George
British Journal of Pharmacology|February 10, 2022
How good are our models of cardiovascular disease?Christopher G Sobey, Grant R Drummond, Christopher H George
Cardiovascular Research|September 15, 2004
Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac deathN Lowri Thomas, Christopher H George, F Anthony Lai
Biochemical and Biophysical Research Communications|April 23, 2005
Differential Ca2+ sensitivity of RyR2 mutations reveals distinct mechanisms of channel dysfunction in sudden cardiac deathN Lowri Thomas, F Anthony Lai, Christopher H George
Future Cardiology|October 7, 2009
Ryanodine receptor dysfunction in arrhythmia and sudden cardiac deathChristopher H George, N Lowri Thomas, F Anthony Lai
The Biochemical Journal|November 22, 2002
In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6Christopher H George, Rina Sorathia, Benedicte M A Bertrand, et al.
The Journal of Biological Chemistry|May 20, 2003
Dysregulated ryanodine receptors mediate cellular toxicity: restoration of normal phenotype by FKBP12.6Christopher H George, Gemma V Higgs, John J Mackrill, et al.
Expert Opinion on Therapeutic Patents|July 26, 2016
Pleiotropic mechanisms of action of perhexiline in heart failureChristopher H George, Alice N Mitchell, Ryan Preece, et al.
Scientific Reports|August 15, 2020
Cupid, a cell permeable peptide derived from amoeba, capable of delivering GFP into a diverse range of speciesDaniel Fenton, Dylan Phillips, Anne Maddison, et al.
Journal of Molecular and Cellular Cardiology|November 4, 2006
Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapiesChristopher H George, Hala Jundi, N Lowri Thomas, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|December 5, 2022
How good are our models of cardiovascular disease? Introducing our themed issue on preclinical models for cardiovascular disease researchChristopher G Sobey, Grant R Drummond, Christopher H George
British Journal of Pharmacology|February 10, 2022
How good are our models of cardiovascular disease?Christopher G Sobey, Grant R Drummond, Christopher H George
Cardiovascular Research|September 15, 2004
Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac deathN Lowri Thomas, Christopher H George, F Anthony Lai
Biochemical and Biophysical Research Communications|April 23, 2005
Differential Ca2+ sensitivity of RyR2 mutations reveals distinct mechanisms of channel dysfunction in sudden cardiac deathN Lowri Thomas, F Anthony Lai, Christopher H George
Future Cardiology|October 7, 2009
Ryanodine receptor dysfunction in arrhythmia and sudden cardiac deathChristopher H George, N Lowri Thomas, F Anthony Lai
The Biochemical Journal|November 22, 2002
In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6Christopher H George, Rina Sorathia, Benedicte M A Bertrand, et al.
The Journal of Biological Chemistry|May 20, 2003
Dysregulated ryanodine receptors mediate cellular toxicity: restoration of normal phenotype by FKBP12.6Christopher H George, Gemma V Higgs, John J Mackrill, et al.
Expert Opinion on Therapeutic Patents|July 26, 2016
Pleiotropic mechanisms of action of perhexiline in heart failureChristopher H George, Alice N Mitchell, Ryan Preece, et al.
Scientific Reports|August 15, 2020
Cupid, a cell permeable peptide derived from amoeba, capable of delivering GFP into a diverse range of speciesDaniel Fenton, Dylan Phillips, Anne Maddison, et al.
Journal of Molecular and Cellular Cardiology|November 4, 2006
Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapiesChristopher H George, Hala Jundi, N Lowri Thomas, et al.
Pageof 6